Maria Anthony Yialamas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internal Medicine | 9 | 2022 | 1051 | 2.530 |
Why?
|
| Internship and Residency | 18 | 2024 | 5880 | 2.230 |
Why?
|
| Education, Medical, Graduate | 6 | 2021 | 2373 | 1.020 |
Why?
|
| Burnout, Professional | 3 | 2022 | 704 | 0.930 |
Why?
|
| Physicians, Women | 2 | 2020 | 508 | 0.870 |
Why?
|
| Computers, Handheld | 2 | 2015 | 210 | 0.850 |
Why?
|
| Hierarchy, Social | 1 | 2021 | 24 | 0.740 |
Why?
|
| Hypogonadism | 4 | 2018 | 798 | 0.690 |
Why?
|
| Verbal Behavior | 1 | 2021 | 335 | 0.660 |
Why?
|
| Physical Examination | 4 | 2015 | 1255 | 0.660 |
Why?
|
| Anemia, Pernicious | 1 | 2018 | 15 | 0.630 |
Why?
|
| Personnel Selection | 1 | 2020 | 196 | 0.600 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2018 | 118 | 0.570 |
Why?
|
| Pancytopenia | 1 | 2017 | 102 | 0.550 |
Why?
|
| Cultural Diversity | 1 | 2020 | 369 | 0.530 |
Why?
|
| Teaching Rounds | 1 | 2020 | 275 | 0.510 |
Why?
|
| Muscle Weakness | 1 | 2018 | 412 | 0.490 |
Why?
|
| Physician-Patient Relations | 3 | 2018 | 3249 | 0.480 |
Why?
|
| Medicine | 1 | 2022 | 942 | 0.450 |
Why?
|
| Testosterone | 7 | 2018 | 2472 | 0.450 |
Why?
|
| Hormone Replacement Therapy | 2 | 2018 | 751 | 0.440 |
Why?
|
| Faculty, Medical | 2 | 2020 | 1203 | 0.440 |
Why?
|
| Physician's Role | 1 | 2020 | 917 | 0.420 |
Why?
|
| Physicians | 2 | 2022 | 4591 | 0.420 |
Why?
|
| Clinical Competence | 4 | 2019 | 4792 | 0.410 |
Why?
|
| Uncertainty | 1 | 2017 | 754 | 0.400 |
Why?
|
| Leadership | 2 | 2023 | 1385 | 0.400 |
Why?
|
| Endocrinology | 1 | 2018 | 442 | 0.390 |
Why?
|
| Ultrasonography | 2 | 2015 | 5972 | 0.390 |
Why?
|
| Memory Disorders | 1 | 2018 | 1198 | 0.370 |
Why?
|
| Publishing | 1 | 2018 | 833 | 0.370 |
Why?
|
| Spinal Cord | 1 | 2018 | 1818 | 0.340 |
Why?
|
| Curriculum | 2 | 2020 | 3743 | 0.330 |
Why?
|
| Gonadotropins | 2 | 2007 | 241 | 0.330 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 461 | 0.290 |
Why?
|
| Students, Medical | 1 | 2020 | 1936 | 0.270 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2011 | 376 | 0.270 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 702 | 0.220 |
Why?
|
| Decision Making | 1 | 2017 | 3929 | 0.220 |
Why?
|
| Metformin | 1 | 2011 | 906 | 0.210 |
Why?
|
| Sexual Harassment | 1 | 2023 | 82 | 0.210 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2007 | 625 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2017 | 3613 | 0.200 |
Why?
|
| Humans | 40 | 2024 | 761504 | 0.190 |
Why?
|
| Insulin Resistance | 3 | 2010 | 3963 | 0.160 |
Why?
|
| School Admission Criteria | 1 | 2020 | 107 | 0.160 |
Why?
|
| Intrinsic Factor | 1 | 2018 | 4 | 0.160 |
Why?
|
| Videoconferencing | 1 | 2021 | 203 | 0.160 |
Why?
|
| Faculty | 1 | 2021 | 384 | 0.150 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2018 | 43 | 0.150 |
Why?
|
| Pulmonary Heart Disease | 1 | 2017 | 34 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 239 | 0.150 |
Why?
|
| Tick-Borne Diseases | 1 | 2017 | 36 | 0.150 |
Why?
|
| Female | 22 | 2023 | 392644 | 0.150 |
Why?
|
| Insect Bites and Stings | 1 | 2017 | 71 | 0.140 |
Why?
|
| Reference Standards | 1 | 2021 | 1003 | 0.140 |
Why?
|
| Inpatients | 3 | 2019 | 2548 | 0.140 |
Why?
|
| Male | 22 | 2023 | 360804 | 0.130 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 437 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2021 | 803 | 0.130 |
Why?
|
| Doxycycline | 1 | 2017 | 344 | 0.130 |
Why?
|
| Androgens | 1 | 2003 | 1286 | 0.130 |
Why?
|
| Vitamin B 12 | 1 | 2018 | 524 | 0.120 |
Why?
|
| Research Personnel | 1 | 2020 | 588 | 0.120 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2013 | 13 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 12974 | 0.110 |
Why?
|
| Death | 1 | 2017 | 676 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1367 | 0.100 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 243 | 0.100 |
Why?
|
| Exercise Test | 1 | 2019 | 2127 | 0.100 |
Why?
|
| Aging | 2 | 2018 | 8708 | 0.100 |
Why?
|
| Education, Distance | 1 | 2015 | 261 | 0.100 |
Why?
|
| Lyme Disease | 1 | 2017 | 631 | 0.100 |
Why?
|
| Communication | 3 | 2024 | 3873 | 0.090 |
Why?
|
| Learning | 1 | 2019 | 1740 | 0.090 |
Why?
|
| Advance Care Planning | 1 | 2017 | 698 | 0.080 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2009 | 136 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 2012 | 362 | 0.080 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2009 | 81 | 0.080 |
Why?
|
| Quality of Health Care | 2 | 2015 | 4330 | 0.080 |
Why?
|
| Body Composition | 3 | 2010 | 2426 | 0.080 |
Why?
|
| Consensus | 1 | 2018 | 3123 | 0.080 |
Why?
|
| Orchiectomy | 1 | 2010 | 463 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 601 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2011 | 539 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 867 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 10552 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 343 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3688 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2018 | 3905 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2009 | 616 | 0.060 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2011 | 550 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2009 | 409 | 0.060 |
Why?
|
| Middle Aged | 10 | 2019 | 220895 | 0.060 |
Why?
|
| Leydig Cells | 1 | 2005 | 55 | 0.060 |
Why?
|
| Adipokines | 1 | 2007 | 310 | 0.060 |
Why?
|
| Kallmann Syndrome | 1 | 2006 | 139 | 0.060 |
Why?
|
| Hospitalists | 1 | 2009 | 294 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2006 | 257 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1522 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2020 | 3429 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58976 | 0.060 |
Why?
|
| Boston | 4 | 2019 | 9326 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3358 | 0.060 |
Why?
|
| Insulin | 2 | 2010 | 6596 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2005 | 496 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2872 | 0.050 |
Why?
|
| Aged | 8 | 2019 | 169289 | 0.050 |
Why?
|
| Luteinizing Hormone | 3 | 2011 | 820 | 0.050 |
Why?
|
| Patient Satisfaction | 2 | 2012 | 3461 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5440 | 0.050 |
Why?
|
| Stereotyping | 1 | 2023 | 239 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1170 | 0.050 |
Why?
|
| United States | 2 | 2020 | 72334 | 0.050 |
Why?
|
| Adult | 9 | 2021 | 221177 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4414 | 0.040 |
Why?
|
| Policy | 1 | 2024 | 508 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6534 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26125 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7407 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 1866 | 0.040 |
Why?
|
| Melanoma | 1 | 2017 | 5709 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2011 | 726 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2021 | 537 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1923 | 0.040 |
Why?
|
| Glucose | 1 | 2009 | 4346 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7856 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 11669 | 0.030 |
Why?
|
| Ankyrins | 1 | 1995 | 123 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2010 | 6391 | 0.030 |
Why?
|
| Postmenopause | 1 | 2003 | 2513 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2011 | 12953 | 0.030 |
Why?
|
| Oxygen | 1 | 2005 | 4227 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5840 | 0.030 |
Why?
|
| Estradiol | 2 | 2011 | 1937 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2003 | 1606 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 500 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2013 | 196 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 4948 | 0.030 |
Why?
|
| Models, Educational | 1 | 2015 | 373 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2003 | 2639 | 0.030 |
Why?
|
| Cytokines | 1 | 2007 | 7396 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2013 | 269 | 0.030 |
Why?
|
| Mitochondria | 1 | 2005 | 3624 | 0.020 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 6403 | 0.020 |
Why?
|
| Androstenedione | 1 | 2011 | 131 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17904 | 0.020 |
Why?
|
| Aromatase | 1 | 2011 | 147 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 341 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 36426 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1995 | 1093 | 0.020 |
Why?
|
| Infusions, Subcutaneous | 1 | 2009 | 43 | 0.020 |
Why?
|
| Patients' Rooms | 1 | 2009 | 62 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 4016 | 0.020 |
Why?
|
| Procollagen | 1 | 2009 | 187 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 1254 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1852 | 0.020 |
Why?
|
| Observation | 1 | 2009 | 310 | 0.020 |
Why?
|
| Progesterone | 1 | 2011 | 742 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 393 | 0.020 |
Why?
|
| Humeral Fractures | 1 | 2009 | 282 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3882 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2021 | 3801 | 0.020 |
Why?
|
| Base Sequence | 2 | 2013 | 12441 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2009 | 774 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2005 | 245 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3270 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 613 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2005 | 263 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2010 | 1187 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2010 | 1148 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 17635 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
| Waist-Hip Ratio | 1 | 2005 | 518 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2495 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1738 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2005 | 400 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3702 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4740 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1738 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2005 | 575 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3518 | 0.010 |
Why?
|
| Mutation | 3 | 2013 | 30052 | 0.010 |
Why?
|
| Kidney | 1 | 1995 | 7048 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 10723 | 0.010 |
Why?
|
| Young Adult | 3 | 2011 | 59243 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11076 | 0.010 |
Why?
|
| Heterozygote | 1 | 2006 | 2787 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4141 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5247 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 4542 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2006 | 3968 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23995 | 0.010 |
Why?
|
| Software | 1 | 2012 | 4434 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 39967 | 0.010 |
Why?
|
| Leptin | 1 | 2005 | 1597 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 4484 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1995 | 749 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 783 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64680 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 1762 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14031 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74206 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 1646 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 1991 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 12990 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80636 | 0.010 |
Why?
|
| Epithelium | 1 | 1995 | 1603 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1995 | 1967 | 0.010 |
Why?
|
| Muscles | 1 | 1995 | 1576 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4174 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81525 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16591 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4615 | 0.000 |
Why?
|
| Animals | 2 | 2013 | 168459 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2009 | 54425 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13446 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 12148 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 12795 | 0.000 |
Why?
|
| Neurons | 1 | 1995 | 9463 | 0.000 |
Why?
|